Focus:
Central Nervous System
-
17 April 2019 products
Case Study: Epionics Corporate Branding
Erdmann Design offered a comprehensive corporate branding service to start-up company Epionics for the introduction of its new Epionics Spine Monitoring System, including product design, brand design, screen design and...
-
3 April 2019 Comment
Highlights from the 14th International Conference on Alzheimer’s and Parkinson’s Diseases 2019
There is a great unmet need for simple, inexpensive, and non-invasive tests that could be applied on a large scale to screen for Alzheimer's disease (AD). Finding a biomarker in...
-
29 March 2019 Analysis
World Bipolar Day: are repurposed drugs the key to effective treatment?
World Bipolar Day aims to eliminate the social stigma that remains associated with bipolar disorder. This and a deficiency of treatments remain the significant barriers to successful treatment of the...
-
27 March 2019 News
Blue Brain Project clarifies neurons’ structure and role in disease
Swiss Ecole Polytechnique Fédérale de Lausanne (EPFL)’s Blue Brain Project has used a mathematical algorithm to distinguish the shape and structures of pyramidal cells.
-
22 March 2019 News
Biogen and Eisai terminate trial of Alzheimer’s drug on efficacy grounds
Biogen and Eisai have announced they are discontinuing two Phase III trials, Engage and Emerge, evaluating the safety and efficacy of aducanumab in patients with Alzheimer’s disease and mild Alzheimer’s...
-
13 March 2019 News
Irish scientists secure EU funding for Parkinson’s research project
The Royal College of Surgeons in Ireland has been awarded a grant for a new research project that seeks to improve scientific understanding of Parkinson’s disease and lead to the...
-
12 March 2019 News
GeNeuro announces positive results from two-year study of MS drug
Swiss biopharma company GeNeuro has announced tgat its two-year Phase IIb study of temelimab in multiple sclerosis (MS) confirmed the results from a previous 48-week CHANGE-MS trial where the drug...
-
4 March 2019 Comment
Parkinson’s disease is on the rise in every region of the planet
The global burden of Parkinson's disease is increasing over time due to the increasing numbers of older people.
-
28 February 2019 Comment
Britain risks thousands of heart disease and stroke deaths due to Brexit
Depending on the outcome of Brexit, thousands of extra deaths from cardiovascular disease and strokes may occur in Britain over the next decade, a study in the British Medical Journal...
-
26 February 2019 Comment
UCB/Epilepsy Society partnership could transform the treatment of epilepsy
UCB’s £2.5m genomic research programme with Epilepsy Society has the potential to transform the diagnosis and treatment of epilepsy patients